<DOC>
	<DOC>NCT00097565</DOC>
	<brief_summary>This is a prospective, observational, longitudinal, multicenter study of patients with newly diagnosed follicular Non Hodgkin's Lymphoma (NHL) designed to delineate differences in clinical outcome by comparing the effectiveness and safety of common treatment regimens.</brief_summary>
	<brief_title>An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma, Non-Hodgkin</mesh_term>
	<mesh_term>Lymphoma, Follicular</mesh_term>
	<criteria>Signed Informed Consent Form (unless the Institutional Review Board [IRB] has granted a waiver of consent) Signed Authorization for the Use and Disclosure of Health Information document Age â‰¥18 years Histologic documentation of follicular NHL, according to Revised EuropeanAmerican Lymphoma (REAL) classification system, as assessed by the local pathologist and treating physician Initial diagnosis of follicular Bcell NHL within 6 months prior to enrollment Availability of cancerspecific historical data points in the patient's medical records Other indolent or histologic NHL subtypes Diagnosis of lymphoma &gt; 6 months prior to enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Follicular Non-Hodgkin's Lymphoma</keyword>
</DOC>